CCL2 in the Tumor Microenvironment

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2021 Jul 21

PMID 34286437

Citations 22

Authors

Tracy OConnor

Mathias Heikenwalder

Affiliations

Soon will be listed here.

Abstract

The C-C motif chemokine ligand 2 (CCL2) is a crucial mediator of immune cell recruitment during microbial infections and tissue damage. CCL2 is also frequently overexpressed in cancer cells and other cells in the tumor microenvironment, and a large body of evidence indicates that high CCL2 levels are associated with more aggressive malignancies, a higher probability of metastasis, and poorer outcomes in a wide range of cancers. CCL2 plays a role in recruiting tumor-associated macrophages (TAMs), which adopt a pro-tumorigenic phenotype and support cancer cell survival, facilitate tumor cell invasion, and promote angiogenesis. CCL2 also has direct, TAM-independent effects on tumor cells and the tumor microenvironment, including recruitment of other myeloid subsets and non-myeloid cells, maintaining an immunosuppressive environment, stimulating tumor cell growth and motility, and promoting angiogenesis. CCL2 also plays important roles in the metastatic cascade, such as creating a pre-metastatic niche in distant organs and promoting tumor cell extravasation across endothelia. Due to its many roles in tumorigenesis and metastatic processes, the CCL2-CCR2 signaling axis is currently being pursued as a potential therapeutic target for cancer.

Citing Articles

Tumor secretome shapes the immune landscape during cancer progression.

Yang J, Tang S, Saba N, Shay C, Teng Y J Exp Clin Cancer Res. 2025; 44(1):47.

PMID: 39930476 PMC: 11809007. DOI: 10.1186/s13046-025-03302-0.

Development and validation of a prognostic prediction model for endometrial cancer based on CD8+ T cell infiltration-related genes.

Chen C, Pei L, Ren W, Sun J Medicine (Baltimore). 2024; 103(49):e40820.

PMID: 39654198 PMC: 11630932. DOI: 10.1097/MD.0000000000040820.

LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.

Zhao L, Wang G, Qi H, Yu L, Yin H, Sun R Cell Mol Biol Lett. 2024; 29(1):77.

PMID: 38769475 PMC: 11103861. DOI: 10.1186/s11658-024-00592-8.

DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma.

Li C, Zhu X Heliyon. 2024; 10(9):e30642.

PMID: 38765113 PMC: 11101781. DOI: 10.1016/j.heliyon.2024.e30642.

Placenta: an old organ with new functions.

Khorami-Sarvestani S, Vanaki N, Shojaeian S, Zarnani K, Stensballe A, Jeddi-Tehrani M Front Immunol. 2024; 15:1385762.

PMID: 38707901 PMC: 11066266. DOI: 10.3389/fimmu.2024.1385762.

References

Agalioti T, Giannou A, Krontira A, Kanellakis N, Kati D, Vreka M . Mutant KRAS promotes malignant pleural effusion formation. Nat Commun. 2017; 8:15205. PMC: 5440809. DOI: 10.1038/ncomms15205. View

Allavena P, Bianchi G, Zhou D, Van Damme J, Jilek P, Sozzani S . Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol. 1994; 24(12):3233-6. DOI: 10.1002/eji.1830241249. View

Allen C, Hogg N . Monocytes and other infiltrating cells in human colorectal tumours identified by monoclonal antibodies. Immunology. 1985; 55(2):289-99. PMC: 1453624. View

Bailey C, Negus R, Morris A, Ziprin P, Goldin R, Allavena P . Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis. 2007; 24(2):121-30. DOI: 10.1007/s10585-007-9060-3. View

Belmadani A, Tran P, Ren D, Miller R . Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci. 2006; 26(12):3182-91. PMC: 2740990. DOI: 10.1523/JNEUROSCI.0156-06.2006. View

Boddeke E, Meigel I, Frentzel S, Gourmala N, Harrison J, Buttini M . Cultured rat microglia express functional beta-chemokine receptors. J Neuroimmunol. 1999; 98(2):176-84. DOI: 10.1016/s0165-5728(99)00096-x. View

Boring L, Gosling J, Monteclaro F, Lusis A, Tsou C, Charo I . Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9. J Biol Chem. 1996; 271(13):7551-8. DOI: 10.1074/jbc.271.13.7551. View

Bottazzi B, Polentarutti N, Balsari A, Boraschi D, Ghezzi P, Salmona M . Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer. 1983; 31(1):55-63. DOI: 10.1002/ijc.2910310110. View

Brocker E, Zwadlo G, Holzmann B, Macher E, Sorg C . Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer. 1988; 41(4):562-7. DOI: 10.1002/ijc.2910410415. View

10.

CARR M, Roth S, Luther E, ROSE S, Springer T . Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994; 91(9):3652-6. PMC: 43639. DOI: 10.1073/pnas.91.9.3652. View

11.

Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M . Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013; 24(6):695-709. DOI: 10.1016/j.ccr.2013.11.007. View

12.

Charo I, Myers S, Herman A, Franci C, Connolly A, Coughlin S . Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A. 1994; 91(7):2752-6. PMC: 43448. DOI: 10.1073/pnas.91.7.2752. View

13.

Chiu H, Sun K, Chen S, Wang H, Lee M, Tsou Y . Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells. Cytokine. 2012; 59(2):423-32. DOI: 10.1016/j.cyto.2012.04.017. View

14.

Chun E, Lavoie S, Michaud M, Gallini C, Kim J, Soucy G . CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep. 2015; 12(2):244-57. PMC: 4620029. DOI: 10.1016/j.celrep.2015.06.024. View

15.

Cochran B, Reffel A, Stiles C . Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 1983; 33(3):939-47. DOI: 10.1016/0092-8674(83)90037-5. View

16.

Combadiere C, Ahuja S, Van Damme J, Tiffany H, Gao J, Murphy P . Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem. 1995; 270(50):29671-5. DOI: 10.1074/jbc.270.50.29671. View

17.

Coussens L, Tinkle C, Hanahan D, Werb Z . MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000; 103(3):481-90. PMC: 2843102. DOI: 10.1016/s0092-8674(00)00139-2. View

18.

Crowther M, Brown N, Bishop E, Lewis C . Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 2001; 70(4):478-90. View

19.

Desbaillets I, Tada M, Tribolet N, Diserens A, Hamou M, Van Meir E . Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer. 1994; 58(2):240-7. DOI: 10.1002/ijc.2910580216. View

20.

Doranz B, Rucker J, Yi Y, Smyth R, Samson M, Peiper S . A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996; 85(7):1149-58. DOI: 10.1016/s0092-8674(00)81314-8. View